Kalliopi P Siziopikou

  • 2023 Citations
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.

Certifications and Licenses

Anatomic Pathology

Training Experience

1994Residency, Beth Israel Deaconess Medical Center, Boston
1995Fellowship, Beth Israel Deaconess Medical Center, Boston

Education/Academic qualification

PhD, Rush Medical College

… → 1990

MD, Aristotle's University of Thessaloniki

… → 1985

Research interests

  • Breast Cancer
  • Breast Disease
  • Cancer Biology
  • Pathology

Fingerprint Dive into the research topics where Kalliopi P Siziopikou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Breast Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Carcinoma, Intraductal, Noninfiltrating Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma, Ductal, Breast Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Alveolar Macrophages Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2014 2016

Research Output 1990 2019

1 Citation (Scopus)

The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS) of the Breast

Ubago, J. M., Blanco Jr, L. Z., Shen, T. & Siziopikou, K. P., Jul 5 2019, In : American journal of clinical pathology. 152, 2, p. 169-176 8 p.

Research output: Contribution to journalArticle

Carcinoma, Intraductal, Noninfiltrating
Epidermal Growth Factor
Breast
Ligands
Tumor-Infiltrating Lymphocytes
Fluorescence In Situ Hybridization
Reflex
Breast Neoplasms
Chromosomes, Human, Pair 17
Immunohistochemistry
11 Citations (Scopus)
1-Phosphatidylinositol 4-Kinase
Breast Neoplasms
Maximum Tolerated Dose
Exanthema
Disease-Free Survival
25 Citations (Scopus)

IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity

Chiang, S., Weigelt, B., Wen, H. C., Pareja, F., Raghavendra, A., Martelotto, L. G., Burke, K. A., Basili, T., Li, A., Geyer, F. C., Piscuoglio, S., Ng, C. K. Y., Jungbluth, A. A., Balss, J., Pusch, S., Baker, G. M., Cole, K. S., Von Deimling, A., Batten, J. M., Marotti, J. D. & 13 others, Soh, H. C., McCalip, B. L., Serrano, J., Lim, R. S., Siziopikou, K. P., Lu, S., Liu, X., Hammour, T., Brogi, E., Snuderl, M., Iafrate, A. J., Reis-Filho, J. S. & Schnitt, S. J., Dec 15 2016, In : Cancer Research. 76, 24, p. 7118-7129 12 p.

Research output: Contribution to journalArticle

Papillary Carcinoma
Breast Neoplasms
Mutation
Exome
Isocitrate Dehydrogenase
95 Citations (Scopus)

Phyllodes tumours of the breast: A consensus review

Tan, B. Y., Acs, G., Apple, S. K., Badve, S., Bleiweiss, I. J., Brogi, E., Calvo, J. P., Dabbs, D. J., Ellis, I. O., Eusebi, V., Farshid, G., Fox, S. B., Ichihara, S., Lakhani, S. R., Rakha, E. A., Reis-Filho, J. S., Richardson, A. L., Sahin, A., Schmitt, F. C., Schnitt, S. J. & 5 others, Siziopikou, K. P., Soares, F. A., Tse, G. M., Vincent-Salomon, A. & Tan, P. H., Jan 1 2016, In : Histopathology. 68, 1, p. 5-21 17 p.

Research output: Contribution to journalReview article

Phyllodes Tumor
Consensus
Breast
Fibroadenoma
Neoplasm Grading